Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement

Authors

Alex Knee, Baystate HealthFollow
Doug Salvador MD, Baystate HealthFollow
Erica Housman, Baystate HealthFollow
Gladys Fernandez MD, Baystate HealthFollow
Armando Paez MD, Baystate HealthFollow

Author Department

Medicine; Infectious Diseases; Pharmacy; Surgery

Document Type

Article, Peer-reviewed

Publication Date

12-2023

Abstract

We conducted a retrospective exploratory study evaluating factors associated with selection to receive and infusion with coronavirus disease 2019 monoclonal antibodies. While priority was given to high-risk patients, patients with increased Social Vulnerability Index scores were less likely to present for infusion, raising concern that social factors created barriers to treatment.

Keywords: COVID-19; Social Vulnerability Index (SVI); health disparities; monoclonal antibodies; pandemic.

Recommended Citation

Brenner S, Knee A, Salvador D, Housman E, Fernandez G, Paez A. Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement. Open Forum Infect Dis. 2023 Dec 26;11(2):ofad665. doi: 10.1093/ofid/ofad665.

PMID

38328493